Soleus Capital Initiates Discussions with Board and Management of Theratechnologies (THTX) on Value Enhancement Strategies

Key Summary: On November 28, 2023, Soleus Capital (10.5%) communicated with the Board and management about enhancing stockholder value, including the potential appointment of a designated candidate to the Board and engaging an investment bank for strategic transactions.

Market Cap: $104 million | Theratechnologies Inc., a biopharmaceutical company, focus…